Heme oxygenase (HO) is an antioxidant that has been implicated as a potential therapeutic treatment in both zebrafish and mouse models of dmd (Chan et al., 2016; Kawahara et al., 2014). This evidence concerns the gene HMOX1 and Duchenne muscular dystrophy.